Journal of Alzheimer's Disease·Aug 10A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's DiseaseExperiments in miceCognitive impairmentPaper